Laurion Capital Management »

Taysha Gene Therapies shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $471k 164k 2.87
2023-06-30 $775k 1.2M 0.66
2023-03-31 $1.0M 1.3M 0.80
2022-12-31 $2.9M 1.3M 2.26
2022-09-30 $854k 443k 1.93
2022-06-30 $1.6M 443k 3.72

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Abbvie Put Option (ABBV)
Blackrock (BLK)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Goldman Sachs (GS)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Strategy Cl A New Call Option (MSTR)
International Business Machines (IBM)
NVIDIA Corporation Call Option (NVDA)
Honeywell International (HON)

View all positions for Laurion Capital Management

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings
Geode Capital Management

View all funds holding Taysha Gene Therapies